Etravirine Tablet
Product Images NDC 80005-113

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etravirine (NDC 80005-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carnegie Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemicalstructure)

FDA Label Image

Containerlabel100mg (Containerlabel100mg)

Etravirine Tablets are a prescription medicine that has to be stored at 25°C (77°F) temperature and protected from moisture. The tablets manufactured by Carnegie Pharmaceuticals LLC contain 100 mg of etravirine, but the dosage information is available in the package insert. It is important to keep the tablets out of reach of children. The packaging includes 120 tablets, and the NDC for the same is 80005-112-12. It is advised to consult the healthcare provider before taking the tablets to know about the medications that should not be taken along with Etravirine.*

FDA Label Image

Containerlabel200mg (Containerlabel200mg)

This is the packaging and labeling information for Etravirine Tablets, containing 200mg of etravirine per tablet. The package should be stored at room temperature, with excursions allowed between 15-30°C, in the original bottle and protected from moisture. The usual dosage information is not provided and should be found in the package insert. Additionally, caution should be taken to not take certain medications with Etravirine Tablets, as advised by a healthcare provider. The tablets are manufactured by Carnegie Pharmaceuticals LLC and are available by prescription only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.